التفاصيل البيبلوغرافية
| العنوان: |
Ticagrelor as an alternative in clopidogrel-associated neutropenia. |
| المؤلفون: |
Shah, Rahman, Keough, Leigh Anne, Belalcazar-Portacio, Astrid, Ramanathan, Kodangudi B. |
| المصدر: |
Platelets; Feb2015, Vol. 26 Issue 1, p80-82, 3p |
| مصطلحات موضوعية: |
ASPIRIN, THROMBOSIS prevention, PLATELET aggregation inhibitors, CLOPIDOGREL, NEUTROPENIA, DRUG efficacy |
| مستخلص: |
Aspirin in combination with platelet P2Y12 receptor blocker has become the mainstay antiplatelet treatment strategy for the prevention of stent thrombosis. Ticlopidine was the first widely used P2Y12 receptor blockers, but clopidogrel has mostly replaced the use of ticlopidine due to its more favorable adverse event profile on bone marrow. However, when clopidogrel induced bone marrow toxicity occurs, little is known about the efficacy and safety of alternative treatments, and thus, in these cases, medical decisions may be very difficult. We report a case of clopidogrel-induced severe neutropenia in a patient treated with coronary stent and safety of alternative treatment with ticagrelor. [ABSTRACT FROM AUTHOR] |
|
Copyright of Platelets is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
